NA
CRL icon

NewEdge Advisors’s Charles River Laboratories CRL Stock Holding History

NewEdge Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$551K Buy
3,195
+2,933
+1,119% +$544K ﹤0.01% 1907
2025
Q4 		$52.3K Hold
262
– – ﹤0.01% 2946
2025
Q3 		$41K Sell
262
-180
-41% -$28.6K ﹤0.01% 2887
2025
Q2 		$67.1K Buy
442
+4
+0.9% +$533 ﹤0.01% 2574
2025
Q1 		$65.9K Sell
438
-86
-16% -$14.4K ﹤0.01% 2449
2024
Q4 		$96.7K Sell
524
-122
-19% -$23.5K ﹤0.01% 2290
2024
Q3 		$127K Sell
646
-1,668
-72% -$347K ﹤0.01% 2122
2024
Q2 		$478K Sell
2,314
-1,025
-31% -$232K ﹤0.01% 1447
2024
Q1 		$905K Buy
3,339
+812
+32% +$194K 0.01% 1047
2023
Q4 		$553K Buy
2,527
+469
+23% +$92.2K 0.01% 1229
2023
Q3 		$403K Buy
2,058
+206
+11% +$42.3K ﹤0.01% 1281
2023
Q2 		$389K Buy
1,852
+92
+5% +$18.3K ﹤0.01% 1317
2023
Q1 		$355K Buy
1,760
+474
+37% +$107K ﹤0.01% 1293
2022
Q4 		$263K Buy
+1,286
New +$281K 0.01% 1069
2022
Q1 		– Sell
-2,670
Closed -$1.01M – 1244
2021
Q4 		$1.01M Sell
2,670
-1,634
-38% -$635K 0.02% 729
2021
Q3 		$1.78M Buy
4,304
+786
+22% +$326K 0.04% 345
2021
Q2 		$1.3M Buy
+3,518
New +$1.17M 0.03% 413
2017
Q3 		– Sell
-22
Closed -$2.18K – 507
2017
Q2 		$2.18K Buy
+22
New +$2.02K ﹤0.01% 1292

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

NewEdge Advisors's CRL Position: Q1 2026 in Review

NewEdge Advisors increased its Charles River Laboratories (CRL) stake by 1,119% in Q1 2026, buying an estimated $544K and bringing the position to 3,195 shares worth $551K. The position accounts for ﹤0.01% of the portfolio, ranked #1907.

NewEdge Advisors first reported a position in CRL in Q2 2017 and has held it in 18 quarters since. The position peaked at $1.78M in Q3 2021. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • NewEdge Advisors held 3,195 shares of Charles River Laboratories worth $551K as of Q1 2026.
  • NewEdge Advisors bought 2,933 Charles River Laboratories shares in Q1 2026, an estimated $544K.
  • Charles River Laboratories made up ﹤0.01% of NewEdge Advisors's portfolio in Q1 2026, its #1907 holding.
  • NewEdge Advisors first reported a position in Charles River Laboratories in Q2 2017 and has held it in 18 quarters since.
  • NewEdge Advisors's Charles River Laboratories position peaked at $1.78M in Q3 2021.
  • 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.